Breaking Family of Deceased Teen Hires Audio Experts to Analyze Distress Call DACA Recipient Files Lawsuit After Deportation, Status Termination Notice Apple Exceeds Q3 Expectations Fueled by Strong iPhone and MacBook Performance Investors Buy Unpaid Property Tax Debts in Ohio, Sparking Predatory Lending Concerns Scouting America Removes Dedicated Diversity Spaces at National Jamboree Amid Pentagon Pressure

Thursday July 30, 2026

Reporter

Insilico Medicine

4Articles Published

5Communities Covered

Published Articles

Press Release

Insilico Medicine Launches the Industry’s First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science

11 hours ago

Press Release

Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma

Jul 29

Press Release

Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors

Jul 27

Press Release

Targeting the $100 Billion Market: Insilico Medicine Nominates AI-driven Novel PCC ISM9528 for Pain Management

Jul 22